Stocks to Buy in December. Part II.


ARK Genome Revolution (ARKG)

Entry: Unlock

Price target: 30.00-32.00

Second PT: Unlock

The global genome editing market reached a valuation of $7.38 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 17.18%, reaching an impressive $30 billion by 2032. While the field is still in its early stages, advancements in medical technology suggest that gene editing is poised for transformative growth. Technologies such as CRISPR-Cas9 are already making waves by enabling precise modification of genes associated with diseases like sickle cell anemia, cystic fibrosis, and muscular dystrophy. Additionally, gene editing is being leveraged to engineer immune cells, such as CAR-T cells, to more effectively target and destroy cancer cells, and even to combat viruses like HIV by altering human cells to resist infection or directly editing the viral genome.  

The impact of gene editing extends far beyond human health. In agriculture, it has led to the development of drought-resistant, pest-resistant, and nutrient-enriched crops, bolstering food security while reducing dependency on chemical pesticides. In livestock, genetic modifications have enhanced disease resistance and productivity, improving overall efficiency. Environmental applications are equally transformative, spanning efforts like the conservation of endangered species, controlling invasive species, and optimizing biofuel production.  

These advancements showcase the immense potential of gene editing to revolutionize science and improve lives worldwide. Recognizing this opportunity, forward-thinking investors are increasingly turning their attention to companies driving innovation in this space. One such avenue is the ARK Genome Revolution ETF, which provides exposure to 38 leading companies in gene editing and related fields. This ETF mitigates the risks of investing in individual companies, many of which are in early stages, offering a diversified and less risky way to capitalize on the industry’s growth.  

Hyper Stocks Analysis: We believe gene editing represents one of the most significant investment opportunities of the coming decade. Its potential may rival that of artificial intelligence, with the two likely to converge in applications that redefine medicine, agriculture, and environmental science. The future is promising, and early investors stand to benefit greatly as this revolutionary technology matures.

Please note that this may take beyond this week to come around to price targets. 

Fastly (FSLY)

Entry: Unlock

Price target: 13.00-14.00

Second PT: Unlock

Fastly is a niche player in the technology sector, providing cutting-edge real-time content delivery network (CDN) services. These services ensure instantaneous delivery of digital content and data with minimal latency, enabling seamless real-time experiences such as live streaming, interactive applications, and instant updates. CDNs are integral to any company seeking to maintain a strong online presence or interact with users in real time. Fastly’s client roster includes prominent names like JetBlue, Ticketmaster, and DoorDash, underscoring its credibility and reach within the space.

Despite its small size, Fastly appears undervalued compared to other leaders in the CDN industry. For example, Cloudflare commands a market cap of $39 billion with $1.3 billion in annual revenue, whereas Fastly’s market cap is just $1.5 billion, despite generating $505 million in annual revenue (2023). Additionally, Fastly’s balance sheet reflects a solid position, with over $1 billion in assets exceeding its liabilities, further supporting the notion that the stock may be undervalued.

Where Is Fastly’s Fundamental Opportunity?  

While Fastly’s 3:1 asset-to-liability ratio highlights its financial stability, the declining asset trend signals challenges, primarily tied to its lack of consistent profitability. The company has yet to achieve positive net income, making profitability its most significant opportunity for growth. 

This landscape may shift as falling interest rates benefit small-cap companies like Fastly, reducing borrowing costs and creating opportunities to invest in critical areas such as research & development and talent acquisition. If Fastly can leverage this environment to improve its bottom line, it stands a strong chance of closing the valuation gap with its larger peers. For investors, the company represents a speculative but potentially rewarding opportunity within the growing CDN market, contingent on its ability to address profitability and maintain operational momentum.

Please note that this may take beyond this week to come around to price targets. 

Lululemon Athletica (LULU) 

Entry: Unlock

Price target: 450.00-455.00

Second PT: Unlock

Breaking into the athletic apparel industry is a monumental challenge, and staying relevant amidst intense competition is even harder. Yet, Lululemon has not only managed to establish itself as a dominant player but has also redefined the space with its innovative approach and unwavering focus on quality and community. Over the past decade, Lululemon has become a household name, reaching nearly $10 billion in annual sales while continuing to deliver robust growth.

Earlier this year, Lululemon’s stock experienced a dip due to stagnant profits in 2023, causing some to question whether the brand could maintain its upward trajectory. However, the company’s recent performance has silenced critics. In its latest quarterly report, net income surged by 41%, underscoring a strong rebound and reaffirming Lululemon's ability to navigate challenges effectively.

Lululemon’s financial health sets it apart from many of its peers in the retail sector:

  • Robust Balance Sheet: The company boasts an impressive 2:1 asset-to-liability ratio, a rarity in the retail industry. This financial stability not only safeguards the business during economic uncertainty but also positions it to capitalize on growth opportunities.
  • Resurgent Free Cash Flow: Over the past twelve months, Lululemon has rebuilt its free cash flow (FCF) to nearly $1.6 billion. This provides the company with ample flexibility to reinvest in its operations, explore strategic initiatives, or return value to shareholders through share buybacks.

Lululemon’s recent rebound in profitability, paired with its exceptional financial metrics, makes it an intriguing option for investors seeking exposure to the premium athletic apparel segment. While competition from giants like Nike and Adidas persists, Lululemon’s unique positioning as a lifestyle brand gives it a competitive edge.

Please note that this may take beyond this week to come around to price targets. 

You've reached the end of our complimentary public watchlist. Unlock for the full list by becoming a member of our Hyper Stocks community. Click here for more information. 

You've reached the end of our complimentary public watchlist. Unlock for the full list by becoming a member of our Hyper Stocks community. Click here for more information. 

You've reached the end of our complimentary public watchlist. Unlock for the full list by becoming a member of our Hyper Stocks community. Click here for more information. 

You've reached the end of our complimentary public watchlist. Unlock for the full list by becoming a member of our Hyper Stocks community. Click here for more information. 

___________________________________

The stocks posted above are the preliminary stocks and set ups we’ll be watching this week. All price points are subject to change based on market performance and sector health. Please do your own research and analysis on these companies/charts before taking on any set ups. Trade at your own risk and as always, good luck! Let’s have a fantastic week.